Cargando…
Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes: Potential role of AGER1 and SIRT1
OBJECTIVE: Increased oxidative stress (OS) and impaired anti-OS defenses are important in the development and persistence of insulin resistance (IR). Several anti-inflammatory and cell-protective mechanisms, including advanced glycation end product (AGE) receptor-1 (AGER1) and sirtuin (silent mating...
Autores principales: | Uribarri, Jaime, Cai, Weijing, Ramdas, Maya, Goodman, Susan, Pyzik, Renata, Chen, Xue, Zhu, Li, Striker, Gary E., Vlassara, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120204/ https://www.ncbi.nlm.nih.gov/pubmed/21709297 http://dx.doi.org/10.2337/dc11-0091 |
Ejemplares similares
-
Chronic Ingestion of Advanced Glycation End Products Induces Degenerative Spinal Changes and Hypertrophy in Aging Pre-Diabetic Mice
por: Illien-Jünger, Svenja, et al.
Publicado: (2015) -
Maternally Transmitted and Food-Derived Glycotoxins: A factor preconditioning the young to diabetes?
por: Mericq, Veronica, et al.
Publicado: (2010) -
Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism
por: Serveaux-Dancer, Marine, et al.
Publicado: (2019) -
Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
por: Portero-Otin, Manuel, et al.
Publicado: (2023) -
Infelix Ager
por: King, W. G.
Publicado: (1913)